statement of purpose:
Problems:
We are trying to find a way to limit the infection of people living in areas with mosquitoes containing Malaria. People traveling to areas overseas near or in Africa are in danger of getting Malaria.Mosquitoes that carry Malaria have nocturnal feeding habits, thus Malaria transmission occurs between dusk and dawn. We’re looking for a solution to prevent malaria.We found out that malaria is transmitted through female mosquitoes because only females bite. Occasionally, it is transmitted through blood transfusion or congenitally from mother to fetus.
Malaria is a life threatening disease that causes shaking chills that can range from moderate to severe high fever, profuse sweating, headache, nausea, vomiting, diarrhea, anemia, muscle pain, convulsions, coma, bloody stools According to http://www.healthline.com/health/malaria#Overview 1 infected mosquitoes carry the Plasmodium parasite. When this mosquito bites you, the parasite is released into your bloodstream.Once the parasites are inside your body, they travel to the liver, where they mature. After several days, the mature parasites enter the bloodstream and begin to infect red blood cells. Within 48 to 72 hours, the parasites inside the red blood cells multiply, causing the infected cells to burst open.The parasites continue to infect red blood cells, resulting in symptoms that occur in cycles that last two to three days at a time.
Previous attempted solution:
There are no available drug regimens guaranteeing 100% protection. Many people attempted to find a way to stop malaria from spreading. One of the solution they attempted solution was the malaria prophylaxis. It is a preventive treatment of malaria. Quinine is also used for malaria treatment. It has no role in prophylaxis. It’s used with a second agent in drug resistant P falciparum. The second agent is doxycycline, tetracycline, pyrimethamine sulfadoxine or clindamycin. Several malaria vaccines are still under development.
There are other attempted solution other than vaccines. For example, they invented a mosquito net treated with permethrin. There are clothes that covers most of the body and have been treated with Permethrin. People also use insect repellents containing appropriate levels of DEET.
Before travelling, many people take antimalarial drugs. It’s doesn't prevent the disease so they need to continue dosing with antimalarials after departure from an endemic area ensures that drug will kill any lingering parasites.
Current Limitation/Present need:
Currently gene therapy has not been performed on humans as of right now since it’s hard to introduce new genes and keep them working in the body. Another limitation we have is that the body can only withstand a certain amount of vitamin B1 before the body responds poorly to it. Also a problem in gene therapy is delivering a gene to the wrong tissue can cause major health problems for the patient.
A limitation in using gene therapy is that we do not know some of the long term effects of it and if someone undergoes Gene therapy their DNA has been modified making it some that there is no way that the inserted gene could be transferred to the gametes. There is also risk of tumor growth. When it comes to gene therapy the immune system along with antibodies and t-cells may destroy the foreign objects in the body. Also the body for certain patients might not allow the repeated gene therapy.
Proposed solution:
We have learned that the Vitamin B1 can prevent mosquitos from biting. If you take more B1 than needed, it will excrete through urine, skin, and sweat. We’re interested in finding a way to genetically modify cells to increase the production of vitamin B1 in humans to prevent malaria carrying mosquitoes from biting.
We’re focusing on something that can prevent malaria.We found out that malaria is transmitted through female mosquitos. We have learned that the Vitamin B1 can prevent mosquitos from biting. If you take more B1 than needed, it will excrete through urine, skin, and sweat. We’re interested in finding a way to genetically modify cells to increase the production of vitamin B1 in humans to prevent malaria carrying mosquitoes from biting.
We are trying to find a way to limit the infection of people living in areas with mosquitoes containing Malaria. People traveling to areas overseas near or in Africa are in danger of getting Malaria.Mosquitoes that carry Malaria have nocturnal feeding habits, thus Malaria transmission occurs between dusk and dawn. We’re looking for a solution to prevent malaria.We found out that malaria is transmitted through female mosquitoes because only females bite. Occasionally, it is transmitted through blood transfusion or congenitally from mother to fetus.
Malaria is a life threatening disease that causes shaking chills that can range from moderate to severe high fever, profuse sweating, headache, nausea, vomiting, diarrhea, anemia, muscle pain, convulsions, coma, bloody stools According to http://www.healthline.com/health/malaria#Overview 1 infected mosquitoes carry the Plasmodium parasite. When this mosquito bites you, the parasite is released into your bloodstream.Once the parasites are inside your body, they travel to the liver, where they mature. After several days, the mature parasites enter the bloodstream and begin to infect red blood cells. Within 48 to 72 hours, the parasites inside the red blood cells multiply, causing the infected cells to burst open.The parasites continue to infect red blood cells, resulting in symptoms that occur in cycles that last two to three days at a time.
Previous attempted solution:
There are no available drug regimens guaranteeing 100% protection. Many people attempted to find a way to stop malaria from spreading. One of the solution they attempted solution was the malaria prophylaxis. It is a preventive treatment of malaria. Quinine is also used for malaria treatment. It has no role in prophylaxis. It’s used with a second agent in drug resistant P falciparum. The second agent is doxycycline, tetracycline, pyrimethamine sulfadoxine or clindamycin. Several malaria vaccines are still under development.
There are other attempted solution other than vaccines. For example, they invented a mosquito net treated with permethrin. There are clothes that covers most of the body and have been treated with Permethrin. People also use insect repellents containing appropriate levels of DEET.
Before travelling, many people take antimalarial drugs. It’s doesn't prevent the disease so they need to continue dosing with antimalarials after departure from an endemic area ensures that drug will kill any lingering parasites.
Current Limitation/Present need:
Currently gene therapy has not been performed on humans as of right now since it’s hard to introduce new genes and keep them working in the body. Another limitation we have is that the body can only withstand a certain amount of vitamin B1 before the body responds poorly to it. Also a problem in gene therapy is delivering a gene to the wrong tissue can cause major health problems for the patient.
A limitation in using gene therapy is that we do not know some of the long term effects of it and if someone undergoes Gene therapy their DNA has been modified making it some that there is no way that the inserted gene could be transferred to the gametes. There is also risk of tumor growth. When it comes to gene therapy the immune system along with antibodies and t-cells may destroy the foreign objects in the body. Also the body for certain patients might not allow the repeated gene therapy.
Proposed solution:
We have learned that the Vitamin B1 can prevent mosquitos from biting. If you take more B1 than needed, it will excrete through urine, skin, and sweat. We’re interested in finding a way to genetically modify cells to increase the production of vitamin B1 in humans to prevent malaria carrying mosquitoes from biting.
We’re focusing on something that can prevent malaria.We found out that malaria is transmitted through female mosquitos. We have learned that the Vitamin B1 can prevent mosquitos from biting. If you take more B1 than needed, it will excrete through urine, skin, and sweat. We’re interested in finding a way to genetically modify cells to increase the production of vitamin B1 in humans to prevent malaria carrying mosquitoes from biting.
efficacy test:
Efficacy test: #1
What you're testing: amount of B1 needed to excrete through the body
Materials to be tested: smaller cells and different amounts of of B1
Independent variable: amounts of b1
dependent variable: excretion of the b1
Controlled variable: incubated room temperature
Amount of b1
Consistently same size and shape petri dish
procedure : 1. Obtain container
2. Put cell containing specified amount of b1 into dish
3. Put dish in incubated room
4. Wait determined amount of time
5. Test area around for excreted b1
Efficacy Test: #2
Objective: We are trying to find a way to genetically modify cells to increase the production of Vitamin B1 in humans to prevent malaria carrying mosquitoes from biting.
Materials to be tested: The amount of B1 in our cells that prevent mosquitoes from biting.
Other Needed Materials: B1, parent cells, mosquitoes, and a human.
Independent Variable: Production of B1 in cells
Dependent Variable: The amount of B1 inputted in the cells
Controlled Variables: Mosquitoes to human ratio, size of area conducted in, the use of female mosquitoes, mosquitoes capable of carrying malaria that do not possess it that contain the Anopheles genus.
Procedure:
What you're testing: amount of B1 needed to excrete through the body
Materials to be tested: smaller cells and different amounts of of B1
Independent variable: amounts of b1
dependent variable: excretion of the b1
Controlled variable: incubated room temperature
Amount of b1
Consistently same size and shape petri dish
procedure : 1. Obtain container
2. Put cell containing specified amount of b1 into dish
3. Put dish in incubated room
4. Wait determined amount of time
5. Test area around for excreted b1
Efficacy Test: #2
Objective: We are trying to find a way to genetically modify cells to increase the production of Vitamin B1 in humans to prevent malaria carrying mosquitoes from biting.
Materials to be tested: The amount of B1 in our cells that prevent mosquitoes from biting.
Other Needed Materials: B1, parent cells, mosquitoes, and a human.
Independent Variable: Production of B1 in cells
Dependent Variable: The amount of B1 inputted in the cells
Controlled Variables: Mosquitoes to human ratio, size of area conducted in, the use of female mosquitoes, mosquitoes capable of carrying malaria that do not possess it that contain the Anopheles genus.
Procedure:
- Select a test subject to start the procedure
- Introduce mosquitoes without B1, and various amounts of B1 to patient
- Record that data of how the mosquitoes react to the B1 patient.
- Restart process on another patient
- Compare results
mentor:
Virtual Mentor and Credentials:
Department of Pharmaceutical Chemistry, L. M. College of Pharmacy, Navrangpura, Ahmedabad 380009, Gujarat, India. [email protected].
New Expert
Susan Wolf, J.D., is a professor of law, and medicine & public policy. Wolf is also the Founding Chair of the Consortium on Law and Values in Health, Environment & the Life Sciences and the Founding Director of the Joint Degree Program in Law, Science & Technology. Professor Wolf is available to discuss topics in health law, law and science, and bioethics, including genetics and genomics; death and dying; assisted suicide and euthanasia; assisted reproduction and women's health care; and managed care.
ContactContact Caroline Marin at 612-624-5680 or at [email protected] to request an interview with any expert from within the University's health sciences programs. For media seeking interviews with experts outside the health sciences, contact the University's news service at (612) 624-5551 or visit the University's experts database.
ContactOffice of the Vice President for Health Sciences
410 ChRC (MMC 501)
426 Church Street SE (map)
Minneapolis, MN 55455
neither of them got back to us.
reflection:
For this project we had to use biotechnology to find a solution in the real world. We decided to attempt a solution to malaria. What we finally decided we wanted to do was try to increase the production of B1 in the body to prevent mosquitoes from from biting. two things we did well was communicating ideas. We all put in new creative ideas even if we weren't sure how it would work.we also did a good job of expressing weather we thought things had potential to work or no way we could figure something out. And did a good job accepting feed back on our ideas. We couldn't have improved our research. It was hard with this project to know where to start our research because we didn't know how solving this problem would be possible because of how little we knew. We also should have gone deeper into our research which was hard because of the limited time we had. I believe this project in all was very interesting and useful.